Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Cervical Carcinoma × sintilimab × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Ovarian Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Locally Advanced Cervical Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Endometrioid 1 Advanced Cervical Cancer 1

Interventions

Cisplatin 2 sintilimab 1 Radiation Dose Hypofractionation 1 Platinum 1 Irinotecan 1 Brachytherapy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06378840 2024-04-23

the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

RenJi Hospital

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡